No Data
Cachet Pharmaceutical's (SZSE:002462) Shareholders Have More To Worry About Than Only Soft Earnings
Jiashitang: Report for the third quarter of 2024
The Market Doesn't Like What It Sees From Cachet Pharmaceutical Co., Ltd.'s (SZSE:002462) Earnings Yet
Kashitang: 2024 Semi-Annual Report
Jiashitang: Summary of the 2024 Semi-Annual Report
Cachet Pharmaceutical (002462.SZ): net income of 0.168 billion yuan in the first half of the year, a year-on-year increase of 8.19%.
Cachet Pharmaceutical (002462.SZ) announced its interim report for the first half of 2024, with a reported revenue of 12.839 billion yuan, a year-on-year decrease of 13.70%; net income attributable to the shareholders of the listed company was 0.168 billion yuan, a year-on-year increase of 8.19%; net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 0.107 billion yuan, a year-on-year decrease of 28.38%; basic earnings per share were 0.58 yuan.
Benign Growth For Cachet Pharmaceutical Co., Ltd. (SZSE:002462) Underpins Stock's 30% Plummet
